IBDEI09A ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4274,1,4,0)
 ;;=4^LEFT HEART FAILURE
 ;;^UTILITY(U,$J,358.3,4274,2)
 ;;=^68721
 ;;^UTILITY(U,$J,358.3,4275,0)
 ;;=581.9^^37^419^17
 ;;^UTILITY(U,$J,358.3,4275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4275,1,3,0)
 ;;=3^581.9
 ;;^UTILITY(U,$J,358.3,4275,1,4,0)
 ;;=4^NEPHROTIC SYNDROME NOS
 ;;^UTILITY(U,$J,358.3,4275,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,4276,0)
 ;;=278.01^^37^419^18
 ;;^UTILITY(U,$J,358.3,4276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4276,1,3,0)
 ;;=3^278.01
 ;;^UTILITY(U,$J,358.3,4276,1,4,0)
 ;;=4^OBESITY,MORBID
 ;;^UTILITY(U,$J,358.3,4276,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,4277,0)
 ;;=278.00^^37^419^19
 ;;^UTILITY(U,$J,358.3,4277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4277,1,3,0)
 ;;=3^278.00
 ;;^UTILITY(U,$J,358.3,4277,1,4,0)
 ;;=4^OBESITY,UNSPEC
 ;;^UTILITY(U,$J,358.3,4277,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,4278,0)
 ;;=278.02^^37^419^20
 ;;^UTILITY(U,$J,358.3,4278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4278,1,3,0)
 ;;=3^278.02
 ;;^UTILITY(U,$J,358.3,4278,1,4,0)
 ;;=4^OVERWEIGHT
 ;;^UTILITY(U,$J,358.3,4278,2)
 ;;=^332745
 ;;^UTILITY(U,$J,358.3,4279,0)
 ;;=423.9^^37^419^21
 ;;^UTILITY(U,$J,358.3,4279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4279,1,3,0)
 ;;=3^423.9
 ;;^UTILITY(U,$J,358.3,4279,1,4,0)
 ;;=4^PERICARDIAL DISEASE NOS
 ;;^UTILITY(U,$J,358.3,4279,2)
 ;;=^123813
 ;;^UTILITY(U,$J,358.3,4280,0)
 ;;=443.9^^37^419^22
 ;;^UTILITY(U,$J,358.3,4280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4280,1,3,0)
 ;;=3^443.9
 ;;^UTILITY(U,$J,358.3,4280,1,4,0)
 ;;=4^PERIPH VASCULAR DIS NOS
 ;;^UTILITY(U,$J,358.3,4280,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,4281,0)
 ;;=272.0^^37^419^23
 ;;^UTILITY(U,$J,358.3,4281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4281,1,3,0)
 ;;=3^272.0
 ;;^UTILITY(U,$J,358.3,4281,1,4,0)
 ;;=4^PURE HYPERCHOLESTEROLEM
 ;;^UTILITY(U,$J,358.3,4281,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,4282,0)
 ;;=272.1^^37^419^24
 ;;^UTILITY(U,$J,358.3,4282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4282,1,3,0)
 ;;=3^272.1
 ;;^UTILITY(U,$J,358.3,4282,1,4,0)
 ;;=4^PURE HYPERGLYCERIDEMIA
 ;;^UTILITY(U,$J,358.3,4282,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,4283,0)
 ;;=588.0^^37^419^25
 ;;^UTILITY(U,$J,358.3,4283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4283,1,3,0)
 ;;=3^588.0
 ;;^UTILITY(U,$J,358.3,4283,1,4,0)
 ;;=4^RENAL OSTEODYSTROPHY
 ;;^UTILITY(U,$J,358.3,4283,2)
 ;;=^104747
 ;;^UTILITY(U,$J,358.3,4284,0)
 ;;=589.0^^37^419^26
 ;;^UTILITY(U,$J,358.3,4284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4284,1,3,0)
 ;;=3^589.0
 ;;^UTILITY(U,$J,358.3,4284,1,4,0)
 ;;=4^UNILATERAL SMALL KIDNEY
 ;;^UTILITY(U,$J,358.3,4284,2)
 ;;=^270363
 ;;^UTILITY(U,$J,358.3,4285,0)
 ;;=593.2^^37^420^1
 ;;^UTILITY(U,$J,358.3,4285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4285,1,3,0)
 ;;=3^593.2
 ;;^UTILITY(U,$J,358.3,4285,1,4,0)
 ;;=4^CYST OF KIDNEY, ACQUIRED
 ;;^UTILITY(U,$J,358.3,4285,2)
 ;;=^270380
 ;;^UTILITY(U,$J,358.3,4286,0)
 ;;=753.10^^37^420^2
 ;;^UTILITY(U,$J,358.3,4286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4286,1,3,0)
 ;;=3^753.10
 ;;^UTILITY(U,$J,358.3,4286,1,4,0)
 ;;=4^CYSTIC KIDNEY DISEASE, UNSPEC
 ;;^UTILITY(U,$J,358.3,4286,2)
 ;;=^104720
 ;;^UTILITY(U,$J,358.3,4287,0)
 ;;=753.17^^37^420^3
 ;;^UTILITY(U,$J,358.3,4287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4287,1,3,0)
 ;;=3^753.17
 ;;^UTILITY(U,$J,358.3,4287,1,4,0)
 ;;=4^MEDULLARY SPONGE KIDNEY
 ;;^UTILITY(U,$J,358.3,4287,2)
 ;;=^67302
 ;;^UTILITY(U,$J,358.3,4288,0)
 ;;=753.13^^37^420^4
 ;;^UTILITY(U,$J,358.3,4288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4288,1,3,0)
 ;;=3^753.13
